MNCs Increasingly Investing In Diseases Affecting Developing Countries – IFPMA
This article was originally published in PharmAsia News
Executive Summary
HONG KONG - Underscoring what may be a subtle but ongoing change in focus for the industry, pharmaceutical companies appear to be increasingly focused on chronic diseases, child and maternal health and other issues of developing countries
You may also be interested in...
Novartis Head of Corporate Research And Chairman, Novartis Institute For Tropical Diseases, Paul Herrling On The Need For Government Funding For Neglected Diseases: An Interview With PharmAsia News
Paul Herrling, Head of Corporate Research at Novartis and Chairman of the Novartis Institute For Tropical Diseases, Singapore spends a week each month in Singapore and for the rest he fulfills his other global commitments. Herrling sat down with PharmAsia News in Singapore to discuss research initiatives for neglected diseases and controversies revolving around his proposal for a fund to research neglected diseases by multiple governments.
Novartis Head of Corporate Research And Chairman, Novartis Institute For Tropical Diseases, Paul Herrling On The Need For Government Funding For Neglected Diseases: An Interview With PharmAsia News
Paul Herrling, Head of Corporate Research at Novartis and Chairman of the Novartis Institute For Tropical Diseases, Singapore spends a week each month in Singapore and for the rest he fulfills his other global commitments. Herrling sat down with PharmAsia News in Singapore to discuss research initiatives for neglected diseases and controversies revolving around his proposal for a fund to research neglected diseases by multiple governments.
Indian Healthcare Industry To Zoom Past $14 Billion In The Next Three Years; Quadruple By 2017 - KPMG Report
MUMBAI - The Indian healthcare industry is estimated to double in value by 2012 at $14.2 billion and more than quadruple by 2017 from the present levels but healthcare infrastructure over the last decade has not kept pace with growth in population. This was revealed in a report, published by global management and accounting consultant KPMG, which predicts that health infrastructure across all Indian states will grow by an average 5.8 percent per annum